Literature DB >> 33680830

Conservative surgery for chronic diabetic foot osteomyelitis: Procedures and recommendations.

José Luis Lázaro-Martínez1, Marta García-Madrid1, Yolanda García-Álvarez1, Francisco Javier Álvaro-Afonso1, Irene Sanz-Corbalán1, Esther García-Morales1.   

Abstract

Osteomyelitis (OM) is the most frequent infection associated with diabetic foot ulcers (DFU) that typically involve the forefoot, the most common location of DFU. Conservative surgical procedures could be attractive alternative that reduces minor and major amputations and avoid future recurrence thus preserving the functionally of the foot. This review aimed to analyze and describe the current evidence on conservative diabetic foot osteomyelitis (DFO) surgical procedures depending on DFU location and indications. A narrative revision of the evidence was carried out by searching Medline through PubMed databases from inception to late July 2020 to identify retrospective, prospective, and randomized controlled trials pertaining to conservative DFO procedures on the forefoot. Seven types of conservative surgical procedures for DFO treatment in the forefoot are described in this review: (1) partial or total distal phalangectomy, (2) arthroplasty of the proximal or distal interphalangeal joint, (3) distal Syme amputation, (4) percutaneous flexor tenotomy, (5) sesamoidectomy, (6) arthroplasty of the metatarsophalangeal joint, and (7) metatarsal head resection. When indicated, conservative surgery for DFUs in patients with chronic forefoot OM is a safe and effective option that increases the chances of healing and reduces the possibility of limb loss and death compared with radical amputation procedures. Since a lack of sufficient evidence supporting this procedure exists, future investigations should be focused on the random clinical trial (RCT) design. The results of prospective trials could help surgeons select the appropriate procedure in each case in order to minimize complications.
© 2020 Delhi Orthopedic Association. All rights reserved.

Entities:  

Keywords:  Conservative surgery; Diabetic foot; Osteomyelitis; Surgical approach

Year:  2020        PMID: 33680830      PMCID: PMC7919928          DOI: 10.1016/j.jcot.2020.12.014

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  42 in total

1.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079

2.  Bone of contention: diagnosing diabetic foot osteomyelitis.

Authors:  Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

Review 3.  The best way to reduce reulcerations: if you understand biomechanics of the diabetic foot, you can do it.

Authors:  José Luis Lázaro-Martínez; Javier Aragón-Sánchez; Francisco Javier Alvaro-Afonso; Esther García-Morales; Yolanda García-Álvarez; Raúl Juan Molines-Barroso
Journal:  Int J Low Extrem Wounds       Date:  2014-09-25       Impact factor: 2.057

4.  Treating diabetic foot osteomyelitis primarily with surgery or antibiotics: have we answered the question?

Authors:  Benjamin A Lipsky
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

5.  How are we to determine whether dietary interventions do more good than harm to hypertensive patients?

Authors:  D L Sackett
Journal:  Can J Physiol Pharmacol       Date:  1986-06       Impact factor: 2.273

Review 6.  Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches.

Authors:  Javier Aragón-Sánchez; Benjamin A Lipsky
Journal:  Expert Rev Anti Infect Ther       Date:  2017-12-19       Impact factor: 5.091

7.  Treatment of diabetic foot osteomyelitis: A surgical critique.

Authors:  Javier Aragón-Sánchez
Journal:  Int J Low Extrem Wounds       Date:  2010-03       Impact factor: 2.057

Review 8.  Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality.

Authors:  William J Jeffcoate; Sicco A Bus; Frances L Game; Robert J Hinchliffe; Patricia E Price; Nicolaas C Schaper
Journal:  Lancet Diabetes Endocrinol       Date:  2016-05-10       Impact factor: 32.069

9.  Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement.

Authors:  F J Aragón-Sánchez; J J Cabrera-Galván; Y Quintana-Marrero; M J Hernández-Herrero; J L Lázaro-Martínez; E García-Morales; J V Beneit-Montesinos; D G Armstrong
Journal:  Diabetologia       Date:  2008-08-22       Impact factor: 10.122

10.  Surgical treatment strategy for diabetic forefoot osteomyelitis.

Authors:  Miki Fujii; Hiroto Terashi; Koichi Yokono
Journal:  Wound Repair Regen       Date:  2016-03-01       Impact factor: 3.617

View more
  4 in total

1.  Dual-functional hybrid quaternized chitosan/Mg/alginate dressing with antibacterial and angiogenic potential for diabetic wound healing.

Authors:  Minqi Wang; Yiqi Yang; Kai Yuan; Shengbing Yang; Tingting Tang
Journal:  J Orthop Translat       Date:  2021-08-12       Impact factor: 5.191

2.  Role of the Healico© Wound Care Smartphone Application in Preventing a Foot Amputation in a 65-Year-Old Patient with Diabetes.

Authors:  Almudena Cecilia Matilla; Alejandra Cobo Mena; Adriana Arpa Giménez; Julia Fernández Morata
Journal:  Am J Case Rep       Date:  2022-05-11

3.  The Fate of Antibiotic Impregnated Cement Space in Treatment for Forefoot Osteomyelitis.

Authors:  Inha Woo; Jeongjin Park; Hyungyu Seok; Tae-gon Kim; Jun Sung Moon; Seung Min Chung; Chul Hyun Park
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

4.  Safety and Efficacy of Several Versus Isolated Prophylactic Flexor Tenotomies in Diabetes Patients: A 1-Year Prospective Study.

Authors:  Mateo López-Moral; Raúl J Molines-Barroso; Yolanda García-Álvarez; Irene Sanz-Corbalán; Aroa Tardáguila-García; José Luis Lázaro-Martínez
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.